+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Injury Treatment Market - Global Forecast 2026-2032- Product Image
Vascular Injury Treatment Market - Global Forecast 2026-2032- Product Image
Sale

Vascular Injury Treatment Market - Global Forecast 2026-2032

  • Report

  • 198 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 4986092
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vascular Injury Treatment Market is projected to reach USD 3.61 Billion in 2026. It is expected to continue growing at a CAGR of 6.15%, reaching USD 5.18 Billion by 2032.

Vascular injury treatment is a time-critical segment of trauma care, cardiovascular surgery, interventional radiology, emergency medicine, and military medicine. Demand is shaped by road traffic trauma, penetrating and blunt injuries, iatrogenic vessel damage, peripheral vascular disease, and complex surgical complications. The WHO reports approximately 1.19 million annual road traffic deaths worldwide, while cardiovascular disease remains the leading global cause of death, underscoring the clinical importance of rapid hemorrhage control, vessel repair, revascularization, and limb salvage.

The market is increasingly defined by hybrid operating rooms, computed tomography angiography, covered stents, embolization products, vascular grafts, vessel-sealing technologies, hemostatic dressings, tourniquets, and multidisciplinary vascular trauma protocols. Providers are prioritizing solutions that reduce time to definitive care, improve patency, limit infection risk, and support damage-control surgery across civilian, defense, and remote-care settings.

Transformative Shifts Reshaping Vascular Injury Care

The vascular injury treatment landscape is shifting from predominantly open surgical repair toward endovascular and hybrid approaches when anatomy, hemodynamics, and facility readiness permit. Covered stent grafts, catheter-directed embolization, resuscitative endovascular balloon occlusion of the aorta, and image-guided vascular access are expanding treatment options while preserving the need for open repair expertise in unstable trauma and complex limb ischemia.

Care pathways are also moving upstream through stronger prehospital hemorrhage control, wider use of tourniquets and hemostatic agents, faster CT angiography triage, and trauma-network protocols. At the same time, manufacturers face rising expectations for clinical evidence, supply resilience, infection prevention, and device compatibility with increasingly digital, data-rich hospital environments.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative force in vascular injury treatment by improving speed, consistency, and operational efficiency rather than replacing clinical judgment. AI-enabled imaging tools can support vessel segmentation, active bleeding detection, anatomic measurement, and prioritization of suspected vascular trauma cases for radiology and surgical teams. Predictive analytics can also help identify patients at higher risk of massive transfusion, limb loss, graft failure, or postoperative complications.

The FDA has authorized hundreds of AI and machine learning-enabled medical devices across clinical categories, demonstrating accelerating regulatory engagement. For vascular injury stakeholders, the opportunity lies in validated AI workflows that shorten door-to-intervention time, optimize inventory, guide device sizing, and support post-repair surveillance. Adoption must be governed by transparency, bias testing, cybersecurity, interoperability, and clinician-led accountability.

Key Regional Insights

North America benefits from mature trauma systems, high use of CT angiography, established vascular surgery and interventional radiology capacity, and strong reimbursement pathways for advanced endovascular repair. Europe combines specialized trauma centers with rigorous device oversight under the Medical Device Regulation, driving demand for evidence-backed vascular grafts, embolization products, and hybrid operating capabilities.

Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN markets invest in emergency care infrastructure, trauma referral systems, and minimally invasive vascular procedures. Latin America shows rising need linked to urban trauma and uneven access to specialist centers, while the Middle East is advancing through premium hospital investment, emergency preparedness, and defense medicine demand. Africa carries a high trauma burden but faces constraints in imaging, blood supply, specialist access, and device affordability, creating opportunities for durable, cost-effective vascular injury treatment solutions aligned with local care capacity.

Key Group Insights

The European Union is a key reference group for vascular injury treatment because harmonized regulation, health technology assessment, and strong vascular surgery networks encourage evidence generation, clinical evaluation, and post-market surveillance. G7 economies lead in research funding, trauma-system maturity, advanced imaging, and adoption of premium endovascular technologies, while NATO demand strengthens innovation in hemorrhage control, battlefield vascular repair, resuscitation, and deployable trauma care.

BRICS countries represent large patient pools, expanding hospital capacity, and growing local manufacturing ambitions, particularly across China, India, and Brazil. ASEAN markets benefit from medical tourism, improving emergency care investment, and regional distribution hubs, while GCC countries are scaling high-acuity hospitals, hybrid operating rooms, and defense-related trauma capabilities. Across these groups, procurement decisions increasingly balance clinical performance, physician training support, regulatory readiness, supply continuity, and total cost of care.

Key Country Insights

The United States remains a leading country for vascular injury treatment due to Level I and II trauma networks, FDA-regulated device innovation, military medicine, and broad adoption of endovascular tools. Canada emphasizes publicly funded trauma care and quality-based adoption, while Mexico and Brazil face strong demand from trauma incidence and expanding private hospital capacity. The United Kingdom, Germany, France, Italy, and Spain combine specialist vascular networks with cost-effectiveness scrutiny, and Russia maintains demand tied to trauma care, defense medicine, and regional hospital modernization.

China and India offer scale, rising cardiovascular and trauma caseloads, and growing domestic medtech production. Japan and South Korea emphasize advanced imaging, precision manufacturing, and high-quality vascular intervention, while Australia benefits from organized trauma systems and strong emergency medicine standards. Country-level success depends on regulatory navigation, physician training, distributor strength, reimbursement fit, hospital readiness, and proof that products improve survival, limb salvage, procedural efficiency, or long-term vessel patency.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize solutions that reduce time to hemorrhage control and revascularization across prehospital, emergency, hybrid operating room, and intensive care settings. Investment should focus on clinically differentiated covered stents, grafts, embolics, vascular access tools, hemostatic products, and digital planning platforms supported by peer-reviewed outcomes and real-world evidence.

Companies should build regional strategies around trauma-system maturity, reimbursement, training needs, and local procurement behavior. Recommended actions include partnering with trauma centers for registries, developing AI governance frameworks, strengthening supply-chain redundancy, offering simulation-based clinician education, and designing cost-tiered portfolios for high-growth emerging markets. Success will favor organizations that combine device innovation with workflow integration and measurable patient outcome improvements.

Research Methodology

This executive summary is based on triangulated secondary research and market intelligence from verified public sources, including the World Health Organization, World Bank, OECD health indicators, national trauma and public health agencies, FDA medical device databases, European regulatory guidance, peer-reviewed vascular surgery and trauma literature, and recognized clinical guidelines from vascular and trauma societies.

The analysis evaluates demand drivers, care pathways, technology adoption, regional health infrastructure, regulatory dynamics, and competitive positioning. Insights were synthesized using cross-source validation to avoid unsupported claims, with emphasis on clinically relevant indicators such as trauma burden, cardiovascular disease prevalence, imaging access, surgical capacity, reimbursement structures, and adoption of endovascular and AI-enabled technologies.

Conclusion

Vascular injury treatment is entering a more integrated, technology-enabled era in which rapid diagnosis, hemorrhage control, endovascular capability, open surgical expertise, and post-repair surveillance are converging. The strongest opportunities are tied to systems that can improve survival, preserve limbs, reduce procedure time, and support consistent outcomes across varied care environments.

As trauma volumes, cardiovascular disease burden, surgical complexity, and defense medicine requirements continue to shape demand, industry leaders must align innovation with evidence, affordability, training, and regional access. Organizations that deliver clinically validated, workflow-ready, and scalable vascular injury treatment solutions will be best positioned to sustain long-term relevance.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Vascular Injury Treatment Market, by Product
7.1. Introduction
7.2. Catheters
7.2.1. Aspiration Catheters
7.2.2. Balloon Catheters
7.2.3. Delivery Catheters
7.3. Embolic Protection Devices
7.3.1. Distal Filters
7.3.2. Proximal Occlusion Devices
7.4. Stents
7.4.1. Bare Metal Stents
7.4.2. Covered Stents
7.4.3. Drug Eluting Stents
7.5. Thrombolytic Drugs
7.5.1. Streptokinase
7.5.2. Tissue Plasminogen Activator
7.5.3. Urokinase
7.6. Vascular Grafts
7.6.1. Biological Grafts
7.6.2. Synthetic Grafts
8. Vascular Injury Treatment Market, by Treatment Modalities
8.1. Introduction
8.2. Endovascular Repair
8.2.1. Aortic Stenting
8.2.2. Carotid Stenting
8.2.3. Peripheral Stenting
8.3. Open Surgery
8.4. Pharmacotherapy
8.4.1. Anticoagulants
8.4.2. Antiplatelet Drugs
8.4.3. Thrombolytics
9. Vascular Injury Treatment Market, by Injury Type
9.1. Introduction
9.2. Arterial Injury
9.3. Capillary Injury
9.4. Microvascular Injury
9.5. Venous Injury
10. Vascular Injury Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Vascular Injury Treatment Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Vascular Injury Treatment Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Vascular Injury Treatment Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AngioDynamics, Inc.
15.3. Artivion, Inc.
15.4. B. Braun Melsungen AG
15.5. Becton, Dickinson and Company
15.6. Boston Scientific Corporation
15.7. Cardinal Health Inc.
15.8. Contego Medical, LLC
15.9. Cook Medical Inc.
15.10. Edwards Lifesciences Corporation
15.11. Endologix LLC
15.12. Getinge AB
15.13. Integra LifeSciences Holdings Corporation
15.14. Johnson & Johnson
15.15. LeMaitre Vascular, Inc.
15.16. Medtronic plc
15.17. Merit Medical Systems, Inc.
15.18. Stryker Corporation
15.19. Teleflex Incorporated
15.20. Terumo Corporation
15.21. W. L. Gore & Associates, Inc.
List of Figures
FIGURE 1. GLOBAL VASCULAR INJURY TREATMENT MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VASCULAR INJURY TREATMENT MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VASCULAR INJURY TREATMENT MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VASCULAR INJURY TREATMENT MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL VASCULAR INJURY TREATMENT MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VASCULAR INJURY TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BALLOON CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BALLOON CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BALLOON CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL DELIVERY CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL DELIVERY CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL DELIVERY CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL EMBOLIC PROTECTION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL DISTAL FILTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL DISTAL FILTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL DISTAL FILTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL PROXIMAL OCCLUSION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PROXIMAL OCCLUSION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PROXIMAL OCCLUSION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL BARE METAL STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL BARE METAL STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL BARE METAL STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL COVERED STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL COVERED STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL COVERED STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DRUG ELUTING STENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL THROMBOLYTIC DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL THROMBOLYTIC DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL THROMBOLYTIC DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL STREPTOKINASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL STREPTOKINASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL STREPTOKINASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL TISSUE PLASMINOGEN ACTIVATOR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TISSUE PLASMINOGEN ACTIVATOR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TISSUE PLASMINOGEN ACTIVATOR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL UROKINASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL UROKINASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL UROKINASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL VASCULAR GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICAL GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICAL GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL SYNTHETIC GRAFTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ENDOVASCULAR REPAIR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL ENDOVASCULAR REPAIR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL ENDOVASCULAR REPAIR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AORTIC STENTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL AORTIC STENTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL AORTIC STENTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CAROTID STENTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL CAROTID STENTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CAROTID STENTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL PERIPHERAL STENTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL PERIPHERAL STENTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PERIPHERAL STENTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACOTHERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACOTHERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PHARMACOTHERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ANTICOAGULANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL ANTICOAGULANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL ANTICOAGULANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL ANTIPLATELET DRUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL ANTIPLATELET DRUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ANTIPLATELET DRUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL THROMBOLYTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL THROMBOLYTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL THROMBOLYTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ARTERIAL INJURY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ARTERIAL INJURY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL ARTERIAL INJURY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CAPILLARY INJURY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CAPILLARY INJURY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CAPILLARY INJURY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL MICROVASCULAR INJURY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL MICROVASCULAR INJURY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL MICROVASCULAR INJURY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL VENOUS INJURY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL VENOUS INJURY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL VENOUS INJURY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 123. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 124. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 134. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 135. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 136. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 137. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 138. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 139. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 147. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 148. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 149. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 150. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 151. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 152. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 153. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 154. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 155. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 156. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 157. EUROPE VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 158. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 160. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 161. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 162. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 163. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 164. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 165. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 166. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 167. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 168. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 169. MIDDLE EAST VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 172. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 173. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 174. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 175. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 176. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 177. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 178. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 179. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 180. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 181. AFRICA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 182. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 184. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 185. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 186. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 187. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 188. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 189. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 190. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 191. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 192. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 193. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 194. ASEAN VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 196. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 197. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 198. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 199. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 200. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 201. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 202. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 203. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 204. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 205. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 206. GCC VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 207. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 209. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 210. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 211. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 212. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 213. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 214. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 215. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 216. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 217. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 218. EUROPEAN UNION VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 220. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 221. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 222. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 223. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 224. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 225. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 226. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 227. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 228. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 229. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 230. BRICS VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 231. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 232. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 233. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 234. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 235. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 236. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 237. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 238. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 239. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 240. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 241. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 242. G7 VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 244. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 245. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 246. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 247. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 248. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 249. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 250. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 251. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 252. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 253. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 254. NATO VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. GLOBAL VASCULAR INJURY TREATMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 256. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 257. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 258. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 259. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 260. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 261. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 262. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 263. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 264. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 265. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 266. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 267. UNITED STATES VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 268. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 269. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 270. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 271. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 272. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 273. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 274. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 275. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 276. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 277. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 278. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 279. CANADA VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 280. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 281. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 282. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 283. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 284. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 285. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 286. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 287. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 288. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 289. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 290. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 291. MEXICO VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 292. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 294. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 295. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 296. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 297. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 298. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 299. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 300. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 301. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 302. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 303. BRAZIL VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 304. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 306. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 307. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 308. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 309. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 310. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 311. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 312. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 313. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 314. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 315. UNITED KINGDOM VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 316. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 317. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 318. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 319. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 320. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 321. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 322. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 323. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 324. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 325. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 326. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 327. GERMANY VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 328. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 329. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 330. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 331. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 332. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 333. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY THROMBOLYTIC DRUGS, 2017-2032 (USD MILLION)
TABLE 334. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY VASCULAR GRAFTS, 2017-2032 (USD MILLION)
TABLE 335. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY TREATMENT MODALITIES, 2017-2032 (USD MILLION)
TABLE 336. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY ENDOVASCULAR REPAIR, 2017-2032 (USD MILLION)
TABLE 337. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY PHARMACOTHERAPY, 2017-2032 (USD MILLION)
TABLE 338. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY INJURY TYPE, 2017-2032 (USD MILLION)
TABLE 339. FRANCE VASCULAR INJURY TREATMENT MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 340. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 341. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 342. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY CATHETERS, 2017-2032 (USD MILLION)
TABLE 343. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY EMBOLIC PROTECTION DEVICES, 2017-2032 (USD MILLION)
TABLE 344. RUSSIA VASCULAR INJURY TREATMENT MARKET SIZE, BY STENTS, 2017-2032 (USD MILLION)
TABLE 345. RUSSIA VASCULAR INJURY TREATMENT

Companies Mentioned

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Artivion, Inc.
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Contego Medical, LLC
  • Cook Medical Inc.
  • Edwards Lifesciences Corporation
  • Endologix LLC
  • Getinge AB
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • LeMaitre Vascular, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Stryker Corporation
  • Teleflex Incorporated
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Table Information

Report AttributeDetails
No. of Pages198
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.18 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Peripheral Vascular Devices Market - Global Forecast 2026-2032 - Product Image

Peripheral Vascular Devices Market - Global Forecast 2026-2032

  • Report
  • 197 Pages
  • Global
From
Aortic & Peripheral Vascular Interventional Devices Market - Global Forecast 2026-2032 - Product Image

Aortic & Peripheral Vascular Interventional Devices Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Peripheral Vascular Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Peripheral Vascular Devices - Global Strategic Business Report - Product Image

Peripheral Vascular Devices - Global Strategic Business Report

  • Report
  • 188 Pages
  • Global
From
Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2026-2034 - Product Image

Interventional Cardiology and Peripheral Vascular Devices Market by Product Type, Indication, Age Group, End User, and Region 2026-2034

  • Report
  • 147 Pages
  • Global
From

About the Vascular Injury Treatment Market

The Vascular Injury Treatment market within the context of Cardiovascular Devices is a rapidly growing sector of the medical device industry. It includes a variety of products and services designed to treat vascular injuries, such as endovascular stents, embolic protection devices, and vascular closure devices. These products are used to treat a variety of conditions, including peripheral artery disease, stroke, and aneurysms. The market is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive treatments. Additionally, the rising geriatric population and the increasing awareness of vascular injury treatments are expected to drive the market growth. Some of the major companies in the Vascular Injury Treatment market include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Johnson & Johnson, and Terumo Corporation. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.